Human Fertilisation and Embryology Authority. Minutes of the Executive Licensing Panel

Size: px
Start display at page:

Download "Human Fertilisation and Embryology Authority. Minutes of the Executive Licensing Panel"

Transcription

1 Human Fertilisation and Embryology Authority Minutes of the Executive Licensing Panel Meeting held at HFEA, Finsbury Tower, Bunhill Row, London, EC1Y 8HF on 27 February 2015 Minutes item no. 1 Centre 0325 (Bourn Hall (Norwich)) Renewal Inspection Report Members of the Panel: Juliet Tizzard Director of Strategy & Corporate Affairs (Chair) Paula Robinson Head of Business Planning Ian Peacock Analyst Programmer Members of the Executive in attendance: Sam Hartley Head of Governance & Licensing Dee Knoyle Committee Secretary Declarations of interest: members of the panel declared that they had no conflicts of interest in relation to this item. The panel had before it: HFEA protocol for the conduct of meetings of the Executive Licensing Panel 8th edition of the HFEA Code of Practice Human Fertilisation and Embryology Act 1990 (as amended) decision trees for granting and renewing licences and considering requests to vary a licence (including the PGD decision tree) guidance for members of the Authority and committees on the handling of conflicts of interest approved by the Authority on 21 January 2009 guidance on periods for which new or renewed licences should be granted standing orders and instrument of delegation indicative sanctions guidance HFEA Direction 0008 (where relevant) and any other relevant directions issued by the Authority guide to Licensing compliance and enforcement policy policy on the publication of Authority and committee papers

2 Consideration of Application 1. The panel considered the papers, which included a completed application form, inspection report and licensing minutes for the past three years. 2. The panel noted that this is a treatment and storage centre which provides a full range of licensed treatments. The panel noted that in relation to activity levels this is a small centre. 3. The panel noted that the centre has been licensed by the HFEA since May 2013 and is on a two-year licence due to expire on 30 April The panel noted that in the 12 months to 31 October 2014, the centre provided 369 cycles of treatment (excluding partner intrauterine insemination). 5. The panel noted that for IVF and ICSI, HFEA-held register data for the period 1 August 2013 to 31 July 2014 showed that the centre s success rates were in line with national averages. 6. The panel noted that in 2013 the centre reported that no cycles of partner insemination treatments had been provided. 7. Between 1 August 2013 to 31 July 2014, the centre s clinical multiple pregnancy rate for all IVF, ICSI and FET cycles for all age groups was 10%. This represented performance that was in line with the 10% maximum multiple live birth rate target for this period. 8. The panel noted that at the time of the inspection on 9 and 10 December 2014, the Inspectorate identified five major and three other areas of non-compliance. The panel noted in particular the major non-compliances. The panel noted that the Person Responsible (PR) had committed to fully implement all of the recommendations within the prescribed timescales. However the panel was concerned that the PR s initial response to the report did not provide assurances that these recommendations would be fully implemented. The panel noted that the Inspectorate would continue to monitor the centre s performance closely and failure to implement the recommendations in this report within the prescribed timescales may result in the submission of a further report to a licensing committee with the recommendation that regulatory action be taken in accordance with the Authority s Compliance and Enforcement policy. 9. The panel noted that the success rates were consistent with the national average and the multiple clinical pregnancy rates met the HFEA target. However the PR is encouraged to continue to use the quality management system (QMS) to best effect to monitor and improve their success rates and to continually improve the quality of the service offered to patients. 10. The panel noted that some improvement is required in order for the centre to demonstrate suitability of their practices. 11. The panel noted that following a management review, the PR revised the response to the recommendations made in the renewal inspection report. The Inspectorate was assured that the PR is engaged with the HFEA and the findings of this report, and that the PR had given a commitment to discharge her duty under section 17(1)(d) of the HF&E Act 1990 (as amended) in ensuring that the centre s practices are suitable.

3 12. The panel noted that the Inspectorate recommends the renewal of the centre s treatment and storage licence for a period of four years without additional conditions subject to compliance with the recommendations made in this report being implemented within the prescribed timescales. Decision 13. The panel had regard to its decision tree. It was satisfied that the appropriate application and fee had been submitted and that the application contained the supporting information required by General Directions In light of the issues raised by the Inspectorate in its report, the panel had regard to its indicative applications guidance in relation to length of licence, in particular the history of compliance with statutory requirements and cooperation by the PR. 15. The panel was satisfied that the qualifications and character of the PR are such as is required for the supervision of licenced activities, and the PR has discharged their duty under section 17 of the HF&E Act 1990 (as amended). 16. The panel noted that the premises to be licensed were suitable for the conduct of the licensed activities. 17. The panel noted the key dates for implementation of the recommendations and urged the centre to complete them within the prescribed timescales. The panel endorsed the Inspectorate s recommendation to continue to monitor the centre s performance. The Inspectorate is asked to provide the Executive Licensing Panel with an update report at the most appropriate time within the next 12 months. 18. The panel endorsed the Inspectorate s recommendation to renew the centre s treatment and storage licence for a period of four years without additional conditions. Signed: Date: 13 March 2015 Juliet Tizzard (Chair)

4 Inspection Report Purpose of the Inspection Report This is a report of an inspection, carried out to assess whether this centre complies with essential requirements in providing safe and high quality care to patients and donors. The inspection was scheduled (rather than unannounced) and the report provides information on the centre s application for a renewal of its existing licence. Licences are usually granted for a period of four years. The Authority s Executive Licensing Panel (ELP) uses the application and this report to decide whether to grant a new licence and, if so, whether any additional conditions should be applied to the licence. Date of inspection: 9 and 10 December 2014 Purpose of inspection: Renewal of a licence to carry out treatment and storage Inspection details: The report covers the performance of the centre since the last inspection, findings from the inspection visit and communications received from the centre. Inspectors: Karen Conyers (lead), Janet Kirkland, Sara Parlett, Cathy Hodgson, Tarek Hussain Date of Executive Licensing Panel: 27 February 2015 Centre name Bourn Hall (Norwich) Limited Centre number 0325 Licence number Centre address Person Responsible Licence Holder L/0325/2/c Gateway 11, Unit 3, Farrier Close, Wymondham, Norwich, Norfolk, NR18 OWF, UK Mrs Frances Rose-Smith Dr Thomas Matthews Date licence issued 1 May 2013 Licence expiry date 30 April 2015 Additional conditions applied to this licence None Page 1 of 33

5 Contents Section 1: Summary report... 3 Section 2: Inspection findings Protection of the patient and children born following treatment The experience of patients The protection of gametes and embryos Information management Section 3: Monitoring of the centre s performance Areas of practice requiring action Page 2 of 33

6 Section 1: Summary report Brief description of the centre and its licensing history: Bourn Hall (Norwich) Limited has held a treatment and storage licence with the HFEA since May 2013 and provides a full range of fertility services. The centre provided 369 cycles of treatment (excluding partner intrauterine insemination) in the 12 months to 31 October In relation to activity levels this is a small centre. In June 2013 the ELP agreed to an application to a change of Person Responsible (PR) to Mrs Frances Rose-Smith. The initial licence included an additional condition which stated: That no licensed activity should take place at the centre until the PR provides satisfactory evidence of compliance with the outstanding recommendations relating to the major areas of non-compliance detailed in the report and referenced in paragraph 5 of the Licence Committee minutes. In May 2013 the centre submitted an application to remove the condition imposed on the licence and the Licence Committee were not minded to remove the condition but instead modified it to state: That no licensed activity should take place at the centre until the PR provides evidence that the Executive finds satisfactory of compliance with the outstanding recommendations relating to the major areas of non-compliance detailed in the report and referenced in paragraph 5 of the minutes of the Licence Committee meeting of 28 March For the avoidance of doubt, once such evidence has been provided, licensed activity may take place at the centre. In 2014, the PR again applied to request the removal of the condition, together with relevant evidence and information as requested by the inspector, and the Licence Committee agreed to the removal of the additional condition from the licence. The inspection team is satisfied that the activities carried out at the centre are necessary or desirable in order to provide licensed treatment services. Other licensed activities of the centre include storage of gametes and embryos. Page 3 of 33

7 Pregnancy outcomes 1 For IVF and ICSI, HFEA held register data for the period 1 August 2013 to 31 July 2014 show the centre s success rates are in line with national averages. In 2013 the centre reported that no cycles of partner insemination treatments had been provided. Multiple births 2 The single biggest risk of fertility treatment is a multiple pregnancy. Between 1 August 2013 to 31 July 2014 the centre s clinical multiple pregnancy rate for all IVF, ICSI and FET cycles for all age groups is 10%: this represents performance that is in line with the 10% multiple live birth rate target for this period. 1 The data in the Register may be subject to change as errors are notified to us by clinics, or picked up through our quality management systems. Centre success rates are considered statistically different from the national averages, and multiple pregnancy rates are considered statistically different from the 10% multiple live birth rate target, when p The HFEA use a conversion factor of 1.27 to convert the 10% multiple live birth rate (MLBR) target to a multiple pregnancy rate (MPR) target of 13%. Page 4 of 33

8 Summary for licensing decision Taking into account the essential requirements set out in the Human Fertilisation and Embryology (HF&E) Act 1990 (as amended), the HF&E Act 2008 and the HFEA Code of Practice (CoP), the inspection team considers that it has sufficient information to conclude that: the application has been submitted in the form required; the application has designated an individual to act as the PR; the PR s qualifications and experience comply with section 16 (2) (c) of the HF&E Act 1990 (as amended); the PR has discharged her duty under section 17 of the HF&E Act 1990 (as amended); the premises (including those of relevant third parties) are suitable; the centre s practices are suitable; the application contains the supporting information required by General Direction 0008, in application for renewal of their licence; the centre has submitted an application fee to the HFEA in accordance with requirements. The ELP is asked to note that at the time of the inspection there were a number of areas of practice that required improvement, including five major and three other areas of noncompliance. Since the inspection visit the PR has given a commitment to fully implementing the following recommendations in the prescribed timescales: Major areas of non compliance: The PR should review the centre s processes to ensure that donor sperm samples to be used for treatments are from donors who have been screened in accordance with regulatory requirements. The PR should ensure that procedures for screening of patients, partners and donors are compliant with all relevant regulatory requirements and guidance. The PR should ensure that CE marked medical devices are used where possible. The PR should ensure that the processes by which verbal and written information regarding legal parenthood is provided to patients using donated gametes are clear and well defined within the team. The PR should ensure that all licensed treatment activity is reported to the Authority within the timeframe required by General Direction Other areas that requires improvement: The PR should ensure that documentation of the time of witnessing and records pertinent to the egg collection are completed at the time the procedure takes place. The PR should establish a summary log of cases where multiple embryos have been transferred to a patient who meets the criteria for single embryo transfer. The PR should review sedation practices to ensure they are in line with current professional body guidelines. Recommendation to the Executive Licensing Panel Page 5 of 33

9 The inspection team notes that the success rates are consistent with the national average and their multiple clinical pregnancy rates meet the HFEA target. The PR is encouraged to continue to use the quality management system (QMS) to best effect to monitor and improve their success rates and to continually improve the quality of the service offered to patients. The centre has no critical areas of concern but does have five major areas of concern. Some improvement is required in order for the centre to demonstrate suitability of their practices. The initial responses provided by the PR in responding to this report did not provide sufficient assurance that the PR would fully implement the recommendations as required and may not fulfil her duties under section 17 of the HF&E Act 1990 (as amended). In response to these concerns a management review meeting was held on 6 February 2015 in accordance with paragraph 4.6 of the HFEA s Compliance and Enforcement policy. The conclusion of the management review was that there was likely to be ongoing risk to patients, their gametes and embryos, with particular reference to use of donor sperm which had not been fully screened and the use of a non-ce marked media supplement added to the culture medium. In accordance with paragraph 4.2 of the HFEA s Compliance and Enforcement policy it was agreed that informal action was warranted in the first instance if formal regulatory action was to be avoided. The centre s inspector contacted the PR and advised her of the Executive s concerns and provided her with an opportunity to resubmit her response to the recommendations made in the report. The PR subsequently provided revised responses to the recommendations and these have been updated in the section Areas of practice requiring action at the end of this report. The Executive s review has also been updated accordingly. The Executive is now assured that the PR is engaged with the HFEA and the findings of this report, and that the PR has given a commitment to discharge her duty under section 17(1)(d) of the HF&E Act 1990 (as amended) in ensuring that the centre s practices are suitable. Based on all the information provided to date, the Executive recommends the renewal of the centre s treatment and storage licence for a period of four years without additional conditions subject to compliance with the recommendations made in this report being implemented within the prescribed timescales. The centre s inspector will continue to monitor the centre s performance closely. Failure to implement the recommendations in this report within the prescribed timescales may result in the submission of a further report to the Licence Committee/ ELP with the recommendation that regulatory action be taken in accordance with the Authority s Compliance and Enforcement policy. Page 6 of 33

10 Section 2: Inspection findings This section details what the centre does well and which areas need to be improved to meet essential requirements. We break this down in to four areas covering all the activities of a licensed centre: 1. The protection of the patient, and children born following treatment at this centre 2. The experience of patients at this centre 3. The protection of gametes (sperm and eggs) and embryos at this centre 4. How this centre looks after important information 1. Protection of the patient and children born following treatment Witnessing and assuring patient and donor identification What the centre does well Witnessing (Guidance note 18) The centre s procedures for double checking the identification of gametes and embryos and the patient or donor to whom they relate are broadly compliant with HFEA requirements. This ensures that patients receive treatment using the correct gametes or embryos. What the centre could do better Witnessing (Guidance note 18) In two of five records reviewed the time of the witnessing check when gametes and/or embryos are placed into storage was not documented (SLC T71, Code of Practice 18.8; see recommendation 6). Donor selection criteria and laboratory tests Screening of donors prior to procuring, processing gametes and embryos Payments for donors Donor assisted conception What the centre does well Screening of donors (Guidance note 11) The centre does not currently recruit gamete donors but does provide donor treatments with gametes provided by donors recruited by the Bourn Hall group. Payments for donors (Guidance note 13; General Direction 0001) The centre does not currently recruit gamete donors. Page 7 of 33

11 Donor assisted conception (Guidance note 20) A donor-conceived person is entitled to know details of their donor and any donorconceived genetic siblings they may have. Parents of a donor-conceived child are able to access information on their child s donor (and about any donor-conceived genetic siblings) from the HFEA or the clinic where they received treatment. Therefore it is important that centres use donated gametes or embryos from identifiable donors. The centre s procedures are compliant with HFEA requirements to ensure the donor conceived will be able to receive this information. What the centre could do better Screening of donors (Guidance note 11) Eight out of 22 donor sperm samples used in treatment which had been supplied by their affiliate centre, Bourn Hall Cambridge had not been screened for anti-hepatitis B core antibody (SLC T52b; see recommendation 1). The centre does not have robust processes in place to review the screening results of gamete donors prior to acceptance and use and do not reference the requirement to ensure that additional testing has been carried out where it is required depending on the donor s origins (HTLV-1 antibody SLC T52g) or travel and exposure history and the characteristics of the tissue or cells donated (e.g., Rh D, Malaria, CMV, T.cruzi (SLC T52h; see recommendation 2). Payments for donors (Guidance note 13; General Direction 0001) The centre does not currently recruit donors but the licence renewal application suggests that it may do so in the future. Written information for donors concerning compensation, to be used if recruitment commences, was considered by the inspection team to be inconsistent and potentially misleading. This is not recorded as a non-compliance because donor recruitment is not being performed however, if recruitment commences, the written information should be reviewed against regulatory requirements and a revised copy provided to the centre s inspector. Suitable premises and suitable practices Safety and suitability of premises and facilities Laboratory accreditation Infection control Medicines management Pre-operative assessment and the surgical pathway Multiple births Procuring gametes and embryos Transport and distribution of gametes and embryos Receipt of gametes and embryos Imports and exports Traceability Quality management system Third party agreements Transports and satellite agreements Equipment and materials Page 8 of 33

12 Process validation Adverse incidents What the centre does well Safety and suitability of premises and facilities (Guidance note 25) The centre s premises are suitable. This is important to ensure that all licensed activities are conducted in a suitable environment that is fit for purpose. The centre has procedures in place that are compliant with requirements to ensure that risks are taken into account to ensure patients and staff are in safe surroundings that prevent harm. The centre is compliant with HFEA requirements to process gametes and/or embryos in an environment of appropriate air quality. Laboratory accreditation (Guidance note 25) The centre s laboratories and/or third party laboratories which undertake the diagnosis and investigation of patients, patients partners or donors, or their gametes, embryos or any material removed from them, are partially compliant with HFEA requirements for accreditation by Clinical Pathology Accreditation (CPA) UK Ltd or another body accrediting to an equivalent standard. This is important to assure the quality of the services provided. Infection control The centre has systems in place to manage and monitor the prevention and control of infection that are compliant with guidance. Medicines management The centre has arrangements in place for obtaining, recording, handling, using, keeping, dispensing, administering and disposing of medicines that are compliant with guidance. Pre-operative assessment and the surgical pathway The centre has policies and procedures in place that are broadly compliant with professional body guidelines for pre-operative assessment and management of the surgical pathway. This is important to ensure that all patients are safely assessed and cared for pre, peri and post operatively. Multiple births (Guidance note 7; General Direction 0003) The centre s procedures are broadly compliant with HFEA multiple births minimisation strategy requirements for conducting regular audits and evaluations of the progress and effectiveness of the strategy. The single biggest risk of fertility treatment is a multiple pregnancy. Procurement of gametes and embryos (Guidance note 15) The centre s procedures are compliant with HFEA requirements to: document the justification for the use of the patient s gametes (or embryos created with their gametes) in treatment, based on the patient s medical history and therapeutic indications; where the sperm is procured at home, the centre keeps a record of this in the gamete provider s records. Page 9 of 33

13 Transport and distribution of gametes and embryos (Guidance note 15; General Direction 0009) The centre s procedures for the transport, distribution and recall of gametes and embryos are compliant with HFEA requirements. This is important to ensure that all gametes / embryos sent to other licensed centres within or outside the UK are: packaged and transported in a manner that minimises the risk of contamination and preserves the characteristics and biological functions of the gametes or embryos; shipped in a container that is designed for the transport of biological materials and that maintains the safety and quality of the gametes or embryos; appropriately labelled with the transport conditions, including temperature and time limit being specified; the container/package is secure and ensures that the gametes or embryos are maintained in the specified conditions. All containers and packages are validated as fit for purpose. Receipt of gametes and embryos (Guidance note 15) The centre s procedures for the receipt of gametes and embryos are compliant with HFEA requirements. This is important to ensure that the centre only accepts gametes and embryos from other centres if the gametes and embryos are appropriately labelled and has enough information to permit the gametes and embryos be stored or used in treatment in a way that does not compromise their quality and safety. Imports and exports (Guidance note 16; General Direction 0006) The centre s procedures in place for import and export of gametes and embryos are compliant with HFEA requirements. Traceability (Guidance note 19) The centre s procedures are broadly compliant with HFEA traceability requirements. These requirements are important to ensure that the centre has the ability - to identify and locate gametes and embryos during any step from procurement to use for human application or disposal, to identify the donor and recipient of particular gametes or embryos, to identify any person who has carried out any activity in relation to particular gametes or embryos, and to identify and locate all relevant data relating to products and materials coming into contact with particular gametes or embryos and which can affect their quality or safety. Quality management system (QMS) (Guidance note 23) The centre has a QMS in place that is compliant with HFEA requirements. The establishment and use of a QMS is important to ensure continuous improvement in the quality of treatments and services. Third party agreements (Guidance note 24) The centre s third party agreements are compliant with HFEA requirements. Transport and satellite agreements (Guidance note 24; General Direction 0010) The centre does not have any satellite or transport arrangements. Equipment and materials (Guidance note 26) Page 10 of 33

14 The centre uses equipment and materials that are partially compliant with HFEA requirements. The centre is compliant with HFEA requirements to validate critical equipment. The centre has documented procedures for the operation of critical equipment and procedures to follow if equipment malfunctions. Process validation (Guidance note 15) The centre s procedures are compliant with HFEA requirements to validate critical processes. This ensures that these processes are effective and do not render the gametes or embryos clinically ineffective or harmful to the recipient. Adverse incidents (Guidance note 27) The centre s procedures for reporting adverse incidents are compliant with HFEA requirements. The centre reports all adverse incidents (including serious adverse events and reactions) to the HFEA. The centre investigates all adverse incidents that have occurred. Reporting and investigation of adverse incidents is important to ensure that centres share the lessons learned from incidents and continuously improve the services it offers. What the centre could do better Laboratory accreditation (Guidance note 25) Diagnostic test results are communicated to the centre by the patient's referring clinician. The PR could not be assured of the validity and accuracy of the results of the tests or that they had been performed by a suitably accredited laboratory (SLC T51a; see recommendation 2). Pre-operative assessment and the surgical pathway Patient feedback received at the HFEA included a concern from one patient regarding the sedation that they had received during their treatment at the centre. This was discussed with the PR during the inspection. The inspection team was informed that surgical procedures undertaken at the centre are performed under conscious sedation using protocols drawn up by the clinician at the centre (SLC T2; see recommendation 8). Multiple births (Guidance note 7; General Direction 0003) The centre does not keep a summary log of cases in which multiple embryos have been transferred to a patient who meets the criteria for single embryo transfer (General Direction 0003; see recommendation 7). Traceability (Guidance note 19) Tubes used to collect follicular fluid during egg collections are not labelled and the centre s risk assessment requires a check of the working area (flow hood) to ensure that no unlabelled tubes remain between patients. In one of five records reviewed there was no documentation of the completion of the step confirming that the flow hood was clear of all unlabelled tubes (SLC T101; see recommendation 6). Equipment and materials (Guidance note 26) The following medical device used by the centre is not CE marked: supplement for LifeGlobal culture media (SLC T30; see recommendation 3). The addition of a non-ce Page 11 of 33

15 marked supplement to a CE marked culture media product was discussed with centre staff it is noted that the addition of this product invalidates the CE mark status of the culture medium. Use of the medium is non-compliant with the requirements of SLC T30 which requires the use CE marked medical devices where possible. In a Clinic Focus article provided in April 2013 clinics were advised that in the absence of any prospect that non-ce marked products would meet the requirements of licence conditions, they should implement a plan of action to ensure compliance within the following year. Staff engaged in licensed activity Person Responsible (PR) Staff What the centre does well Person Responsible (Guidance note 1) The PR has complied with HFEA requirements. The PR has academic qualifications in the field of nursing and has two years of practical experience which is directly relevant to the activity to be authorised by the licence. The PR has successfully completed the HFEA PR Entry Programme (T/1240/81). Staff (Guidance note 2) The centre is compliant with HFEA requirements. The centre has suitably qualified and competent staff, in sufficient number, to carry out the licensed activities and associated services. The centre has an organisational chart which clearly defines accountability and reporting relationships. The centre has access to a nominated registered medical practitioner and scientist, within the UK, to advise on and oversee medical and scientific activities respectively. What the centre could do better Nothing identified at this inspection. Welfare of the child and safeguarding What the centre does well Welfare of the child (Guidance note 8) The centre s procedures to ensure that the centre takes into account the welfare of any child who may be born as a result of the licensed treatment, and of any other child who may be affected by that birth before treatment is provided are compliant with HFEA requirements. Safeguarding The centre s procedures are compliant with safeguarding guidance. This ensures that the centre s patients and staff are protected from harm where possible. Page 12 of 33

16 What the centre could do better Nothing identified at this inspection. Embryo testing Preimplantation genetic screening Embryo testing and sex selection What the centre does well Preimplantation genetic screening (Guidance note 9); Embryo testing and sex selection (Guidance note 10) The centre does not carry out embryo testing. What the centre could do better Not reviewed during this inspection. Page 13 of 33

17 2. The experience of patients Patient feedback What the centre does well During the inspection visit no patients agreed to provide feedback to the inspection team. Forty patients provided feedback directly to the HFEA in the time since the last inspection. Of these, 26 patients made positive comments and had compliments about the care that they received. On the basis of this feedback and observations made in the course of the inspection it was possible to assess that the centre: has respect for the privacy and confidentiality of patients in the clinic; gives patients sufficient, accessible and up-to-date information to enable them to make informed decisions; provides patients with satisfactory facilities for their care. What the centre could do better Nothing identified at this inspection. Treating patients fairly Counselling Egg [and sperm] sharing arrangements Surrogacy Complaints Confidentiality and privacy What the centre does well Treating patients fairly (Guidance note 29) The centre s procedures are compliant with the HF& E Act 1990 (as amended) to ensure that staff members understand the requirements for a conscientious objection to providing a particular licensed activity governed by the Act. The centre s procedures are compliant with requirements to ensure that prospective and current patients and donors are treated fairly and that all licensed activities are conducted in a non-discriminatory way. Counselling (Guidance note 3) The centre s counselling procedures are compliant with HFEA requirements. This is important to ensure that counselling support is offered to patients and donors providing relevant consent. Egg and sperm sharing arrangements (Guidance note 12; General Direction 0001) The centre does not currently provide egg or sperm sharing arrangements. Page 14 of 33

18 Surrogacy (Guidance note 14) The centre does not currently undertake surrogacy. Complaints (Guidance note 28) The centre s procedures are compliant with HFEA requirements to seek patient feedback and to be responsive to patient complaints. This is important to ensure that the centre uses patient feedback and any complaints as an opportunity to learn and improve their services. Confidentiality and privacy (Guidance note 30) The centre s procedures are compliant with HFEA requirements to ensure it has respect for the privacy, confidentiality, dignity, comfort and wellbeing of prospective and current patients and donors. What the centre could do better Nothing identified at this inspection. Information What the centre does well Information (Guidance note 4; CH(11)02) The centre s procedures for providing information to patients and / or donors are partially compliant with HFEA requirements. The centre should ensure that they give prospective and current patients and donors sufficient, accessible and up-to-date information to enable them to make informed decisions. What the centre could do better Information (Guidance note 4; CH(11)02) The inspection team found that there was uncertainty within the centre staff as to whose responsibility it was to provide patients using donated gametes with information regarding legal parenthood. In addition written information provided to patients was potentially misleading (SLC T60, Code of Practice 6.2; see recommendation 4). Consent and Disclosure of information, held on the HFEA Register, for use in research What the centre does well Consent (Guidance note 5;6) The centre s procedures for obtaining consent are compliant with HFEA requirements. This ensures that patients and donors have provided all relevant consents before carrying out any licensed activity. Page 15 of 33

19 Legal Parenthood (Guidance note 6) The partners of women treated with donated gametes or embryos, where the couple are neither married nor in a civil partnership, must give their consent in order to become the legal parent of any child born. If this consent is not properly taken, it can have serious consequences, such as the partner having to adopt any child born in order to become the legal parent. In February 2014, the HFEA asked all centres to audit their practices in this area to ensure they are suitable, to report the findings of the audit to the HFEA and to respond to those findings. On this inspection we reviewed the centre s audit and found that it had been performed according to the method specified by the HFEA and that actions had been taken in response to the audit findings. Disclosure of information, held on the HFEA Register, for use in research (General Direction 0005) The centre s procedures for taking consent to disclosure to researchers are compliant with HFEA requirements. This is important to ensure that the HFEA holds an accurate record of patients consent, so that it only releases the patients identifying information, to researchers, with their consent. Information can be used by researchers to improve the knowledge about the health of patients undergoing ART and those born following ART treatment. What the centre could do better Nothing identified at this inspection. Page 16 of 33

20 3. The protection of gametes and embryos Respect for the special status of the embryo What the centre does well The centre s procedures are compliant with the requirements of the HF&E Act 1990 (as amended). This ensures that the centre has respect for the special status of the embryo when conducting licensed activities. licensed activities only take place on licensed premises; only permitted embryos are used in the provision of treatment services; embryos are not selected for use in treatment for social reasons; embryos are not created by embryo splitting; embryos are only created where there is a specific reason to do so which is in connection with the provision of treatment services for a particular woman and embryos are only stored if those embryos were created for a woman receiving treatment services or from whom a third party agreement applies. What the centre could do better Nothing identified at this inspection. Screening of patients Storage of gametes and embryos What the centre does well Screening of patients (Guidance note 17) The centre s procedures for screening patients are partially compliant with HFEA requirements. It is important that gamete providers are appropriately screened to minimise the risks of cross infection during treatment, processing and storage of gametes and/or embryos. Storage of gametes and embryos (Guidance note 17) The centre s procedures for storing gametes and embryos are compliant with HFEA requirements. These measures ensure that the gametes and embryos are stored appropriately to maintain their quality and safety. Furthermore, the centre only stores gametes and embryos in accordance with the consent of the gamete providers. The storage of gametes and embryos is an important service offered by fertility clinics, as it can enable patients to preserve their fertility prior to undergoing other medical treatment such as radiotherapy. The storage of embryos not required for immediate use also means that women can undergo further fertility treatment without further invasive procedures being performed. Page 17 of 33

21 What the centre could do better Screening of patients (Guidance note 17) Blood samples from patients and partners are not obtained within a timeframe specified by the Authority, i.e. within three months before first use (SLC T51b; see recommendation 2). In two of six patient notes audited the anti-hepatitis B core antibody test result was not present in the records and the centre staff were not assured that the tests had been performed (SLCs T50a; see recommendation 2). The centre's processes for screening patients and partners do not include the requirement to consider when additional testing may be required depending on the patient / partner s travel and exposure history and the characteristics of the tissue or cells donated (e.g., Rh D, Malaria, CMV, T.cruzi (SLC T50d; see recommendation 2). Use of embryos for training staff (Guidance note 22) What the centre does well Use of embryos for training staff (Guidance note 22) The centre s procedures for using embryos for training staff are compliant with HFEA requirements. Embryos are only used for the purpose of training staff in those activities expressly authorised by the Authority. What the centre could do better Nothing identified at this inspection. Page 18 of 33

22 4. Information management Record keeping Obligations and reporting requirements What the centre does well Record keeping and document control (Guidance note 31) The centre s procedures for keeping records are compliant with HFEA requirements to ensure that accurate medical records are maintained. Good medical records are essential for the continuity of the patient s care. Obligations and reporting requirements (Guidance note 32; General Direction 0005) The centre s procedures for submitting information about licensed activities to the Authority are broadly compliant with HFEA requirements This is important to ensure the HFEA can supply accurate information to a donor-conceived person and their parents or donors. What the centre could do better Obligations and reporting requirements (Guidance note 32; General Direction 0005) All of the IVF treatments reviewed at inspection had been reported to the HFEA as required by General Direction However 20% (3/15) of the DI treatments had not been reported as required (SLC T9e, T41 and General Direction 0005; see recommendation 5). Page 19 of 33

23 Section 3: Monitoring of the centre s performance Following the initial inspection in 2013, recommendations for improvement were made in relation to three areas of major non-compliance and three other areas of non-compliance. The PR provided information and evidence that all of the recommendations were fully implemented within the prescribed timescales, with the exception of the application for accreditation of the assay laboratories of Bourn Hall Cambridge (centre 0100) by the United Kingdom Accreditation Service (UKAS) Ltd. The application for accreditation was submitted in a timely manner but the completion of the application was delayed by UKAS. Accreditation has now been achieved and all recommendations are complete. On-going monitoring of centre success rates The centre has not been sent any alerts regarding success rates. Page 20 of 33

24 Areas of practice requiring action The section sets out matters which the Inspection Team considers may constitute areas of non compliance. These have been classified into critical, major and others. Each area of non-compliance is referenced to the relevant sections of the Acts, Regulations, Standard Licence Conditions, Directions or the Code of Practice, and the recommended improvement actions required are given, as well as the timescales in which these improvements should be carried out. Critical area of non compliance A critical area of non-compliance is an area of practice which poses a significant risk of causing harm to a patient, donor, embryo or to a child who may be born as a result of treatment services, or a significant shortcoming from the statutory requirements. A critical area of non-compliance requires immediate action to be taken by the Person Responsible. Area of practice and reference None identified at this inspection Action required and timescale for action PR Response Executive Review Page 21 of 33

25 Major area of non compliance A major area of non compliance is a non critical area of non compliance: which poses an indirect risk to the safety of a patient, donor, embryo or to a child who may be born as a result of treatment services which indicates a major shortcoming from the statutory requirements; which indicates a failure of the Person Responsible to carry out his/her legal duties a combination of several other areas of non-compliance, none of which on their own may be major but which together may represent a major area of non-compliance. Area of practice and Reference 1. Eight out of 22 donor sperm samples used in treatment which had been supplied by their affiliate Bourn Hall Cambridge had not been screened for antihepatitis B virus core antibody. This has been categorised as a major (i.e. not critical) non-compliance as the donors had been screened for hepatitis B virus, but with only one of the two required tests. SLC T52b. Action required and timescale for action The PR should ensure that with immediate effect donor sperm samples to be used for treatments are from donors who have been fully screened in accordance with regulatory requirements. The PR should confirm to the centre s inspector that s this action has been implemented when responding to this report. The PR should investigate how donor sperm samples from gamete providers who had not been screened for antihepatitis B core antibody, which is non-compliant with SLC T52b, had been purchased and used. The PR Response Our initial investigation was as follows: We have investigated this finding as requested and wish to reply that the finding is at odds with our understanding of the screeneing requirements, as clarified in Clinic Focus in January We acknolwledge that 8 out of 22 donor sperm samples received and used in treatment have not been screened for anti-hepatitis B virus core antibody. The 8 donors completed their quarrantine and screening process prior to January The Clinic Focus article of the same date gives clarification Executive Review The Executive acknowledges the PR s response and her commitment to fully implementing this recommendation. Further action is required in relation to the completion of the audit due by 10 June Page 22 of 33

26 findings of this investigation including corrective actions and the timescale for implementation should also be submitted to the centre s inspector when responding to this report. Within three months of the implementation of corrective actions identified in the review, the centre should perform an audit to ensure that changes have been effective. A summary report of the findings of the audit should be provided to the centre s inspector by 10 June on the screening for HBv (i.e. gamete donors are screened for both Surface antigen and Core antibody). Since this clarification all donors have been screened as required. The article also indicates that The HFEA will not usually expect centres to carry out screening for anti-hbc retrospectively As the donors in question all had their post quarantine exit screening performed before January 2012 retrospective screening was not undertaken. However following receipt of the executive review and discussions with the inspectorate we accept that our interpretation of the guidance on this matter differed from how the Authority intended it to be read and we wish to advise that from hereon, we will only offer to new patients donor sperm from donors who have been fully screened. We envisage that there will be occasions where patients may wish for donor Page 23 of 33

27 sperm / embryos created using the donor sperm to be used in their treatment examples of such occasions being a patient's wish to try for siblings or to use frozen embryos in storage. In these instances we aim to complete the screening via contact with the donor or through testing of samples held in storage. An audit of this change will be conducted and the summary of the findings will be presented to the centre's inspector by 10 June Blood samples from patients and partners are not obtained within a timeframe specified by the Authority, i.e. within three months before first use. SLC T51b. In two of six patient notes audited the anti-hepatitis B core antibody test result was not present in the records and the centre staff were not assured that the tests had been performed. The PR should ensure that procedures for screening of patients, partners and donors are compliant with all relevant regulatory requirements and guidance. Due to the significant number of issues found relating to screening requirements it is recommended that the PR performs a full review of the centre s screening procedures. This review should include, but not be limited to, the issues Blood samples for patients who do not have current* blood test results will be obtained within the timeframe specified by the authority. *Current blood tests means any required blood test related to ongoing infertility investigations that has been obtained from a blood sample obtained within the previous 24 months. Repeat blood tests will be taken to ensure that no result older than 24 months is used. The Executive acknowledges the PR s response and her commitment to fully implementing this recommendation. The PR has confirmed that the centre will ensure that screening tests for patients and partners will be undertaken within three months before their first use and every 24 months thereafter. Page 24 of 33

28 SLC T50a. The centre's processes for screening patient s, partners and donors do not include the requirement to consider when additional testing may be required depending on the patient/partner s/donor s travel and exposure history and the characteristics of the tissue or cells donated (e.g., Rh D, Malaria, CMV, T.cruzi). SLCs T50d and T52h. Diagnostic test results are communicated to the centre by the patient's referring clinician. The PR could therefore not be assured of the validity and accuracy of the results of the tests or that they had been performed in a suitably accredited laboratory. SLCs T51a. identified during the inspection and described in the body of the report. The findings of the review including corrective actions and the timescale for implementation should be submitted to the centre s inspector by 10 March Within six months of the implementation of corrective actions identified in the review, the centre should perform an audit to ensure that changes have been effective. A summary report of the findings of the audit should be provided to the centre s inspector by 10 September From January 2014 all patients starting treatment have been screened for HB core. A checklist process is in place on IDEAS to ensure that all required testing has been completed. The centres Standard Operating Procedures MN012 and associated Work Instruction MN012-WI04 detail the management of medical and non-routine issues and are included with this response. These documents will be reviewed to ensure they cover all the requirements detailed in the finding. Patient referrals from Consultants at level II facilities (NHS hospitals) detail the diagnostic test results current at the time of referral and these are checked by centre staff for completeness before the referral is accepted. We consider this as adequate assurance that the tests are valid. The updated SOPs reflecting screening requirements and practices are awaited. The Executive acknowledges the PR s responses that the majority of testing will be performed in suitably accredited laboratories. The PR has provided assurance that she has reviewed the centre s processes and will put in place measures to ensure that evaluation of the accreditation status of all testing laboratories used will be undertaken e.g. if tests have been initiated by a GP. A summary of the findings of the review of screening processes due by 10 March 2015 is awaited. Further action is required in relation to the completion of the audit due by 10 September Page 25 of 33

Friday, 22 September 2017 HFEA, 10 Spring Gardens, London SW1A 2BU

Friday, 22 September 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Friday, 22 September 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Panel members Hannah Verdin (Chair) Howard Ryan Jessica Watkin Head of Regulatory Policy Report Developer Policy Manager Members of the

More information

HFEA Executive Licensing Panel Meeting 31 October 2014 Finsbury Tower, Bunhill Row, London, EC1Y 8HF

HFEA Executive Licensing Panel Meeting 31 October 2014 Finsbury Tower, Bunhill Row, London, EC1Y 8HF Minutes Item 1 HFEA Executive Licensing Panel Meeting 31 October 2014 Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8HF Centre 0019 (Aberdeen Fertility Centre) Renewal Treatment & Storage Inspection

More information

Monday, 22 January 2018 HFEA, 10 Spring Gardens, London SW1A 2BU

Monday, 22 January 2018 HFEA, 10 Spring Gardens, London SW1A 2BU Monday, 22 January 2018 HFEA, 10 Spring Gardens, London SW1A 2BU Panel members Members of the Executive External adviser Caylin Joski-Jethi (Chair) Jessica Watkin Helen Crutcher Bernice Ash Nana Gyamfi

More information

HFEA Executive Licensing Panel Meeting 5 September 2014 Finsbury Tower, Bunhill Row, London, EC1Y 8HF

HFEA Executive Licensing Panel Meeting 5 September 2014 Finsbury Tower, Bunhill Row, London, EC1Y 8HF Minutes Item 1 HFEA Executive Licensing Panel Meeting 5 September 2014 Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8HF Centre 0030 (Herts and Essex Fertility Centre) Renewal Treatment & Storage Inspection

More information

Friday, 13 January 2017 HFEA, 10 Spring Gardens, London SW1A 2BU

Friday, 13 January 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Friday, 13 January 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Panel members Juliet Tizzard (Chair) Howard Ryan Trisram Dawahoo Members of the Executive Bernice Ash Secretary Director of Strategy & Corporate

More information

Executive Licensing Panel - minutes

Executive Licensing Panel - minutes Executive Licensing Panel - minutes Centre 0342 (Concept Fertility) Renewal Inspection Report Friday, 27 January 2017 HFEA, 10 Spring Gardens, London SW1A 2BN Panel members Juliet Tizzard (Chair) Paula

More information

Initial licence Inspection Report

Initial licence Inspection Report Initial licence Inspection Report Date of Inspection: 13 February 2013 Purpose of inspection: New licence application Length of inspection: 8 hours Inspectors: Susan Jolliffe Andrew Leonard Victoria Mills

More information

Licence Committee - minutes

Licence Committee - minutes Licence Committee - minutes Centre 0157 (Assisted Reproduction and Gynaecology Centre) Renewal Inspection report Monday, 20 June 2016 HFEA, Level 2, 10 Spring Gardens, London, SW1A 2BU Committee members

More information

15. Procuring, processing and transporting gametes and

15. Procuring, processing and transporting gametes and 15. Procuring, processing and transporting gametes and embryos Version 6.0 On this page: : Extracts from the HFE Act Directions HFEA guidance: Documented procedures: general Patient selection and procurement

More information

Executive Summary for Executive Licensing Panel 20 May Dr Kamal Ahuja. Follow-up inspection 14 April 2010

Executive Summary for Executive Licensing Panel 20 May Dr Kamal Ahuja. Follow-up inspection 14 April 2010 Summary for Licensing Panel 20 May 2010 Centre number 0011 Centre name The London Sperm Bank Person Responsible Dr Kamal Ahuja Background Follow-up inspection 14 April 2010 1. The London Sperm Bank underwent

More information

Licence Committee - minutes

Licence Committee - minutes Licence Committee - minutes Centre 0338 (Reproductive Health Group) Interim Thursday, 11 January 2018 HFEA, 10 Spring Gardens, London, SW1A 2BU Committee members Lee Rayfield (Chair) Ruth Wilde Kate Brian

More information

Human Fertilisation and Embryology Authority 10 Spring Gardens London SW1A 2BU t e w

Human Fertilisation and Embryology Authority 10 Spring Gardens London SW1A 2BU t e w Edition 8.0 First published October 2009 Revised April 2010, April 2011, October 2011, April 2012, October 2013, October 2014, April 2015, October 2015, July 2016, May 2017, October 2017 Human Fertilisation

More information

Friday, 14 July 2017 HFEA, 10 Spring Gardens, London SW1A 2BU

Friday, 14 July 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Friday, 14 July 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Panel members Juliet Tizzard (Chair) Anjeli Kara Jessica Watkin Director of Strategy & Corporate Affairs Regulatory Policy Manager Policy Manager

More information

17. Storage of gametes and embryos

17. Storage of gametes and embryos 17. Storage of gametes and embryos This guidance note contains: Mandatory requirements Extracts from the HFE Act 1990 (as amended) Extracts from licence conditions Reference to relevant HFEA Directions

More information

The Rosie Hospital, Cambridge (0051)

The Rosie Hospital, Cambridge (0051) Human Fertilisation and Embryology Authority Report of Renewal inspection at The Rosie Hospital, Cambridge (0051) Date of Inspection 02.05. 2006 Date of Licence Committee 10 July 2006 1 Contents Key facts

More information

Research Renewal Inspection Report

Research Renewal Inspection Report Research Renewal Inspection Report Date of Inspection: 12 April 2011 Purpose of inspection: Renewal of Research Licence Length of inspection: 6 hours Inspectors Dr Andrew Leonard Mr Parvez Qureshi Inspection

More information

Research Licence Renewal Inspection Report

Research Licence Renewal Inspection Report Research Licence Renewal Inspection Report Project Title The vitrification of blastocysts following biopsy at the earlycleavage stage or blastocyst stage of embryo development A Pilot Study Research Licence

More information

Directions given under the Human Fertilisation and Embryology Act 1990 as amended. Ref: 0006 Version: 4

Directions given under the Human Fertilisation and Embryology Act 1990 as amended. Ref: 0006 Version: 4 Directions given under the Human Fertilisation and Embryology Act 1990 as amended Import and export of gametes and embryo Ref: 0006 Version: 4 These Directions are: GENERAL DIRECTIONS Sections of the Act

More information

Licence Renewal Inspection Report for Treatment and Storage Centres. Brentwood Fertility Centre 0165

Licence Renewal Inspection Report for Treatment and Storage Centres. Brentwood Fertility Centre 0165 Licence Renewal Inspection Report for Treatment and Storage Centres Brentwood Fertility Centre 0165 Date of Inspection: June 29 th 2006 Date of Licence Committee: October 11 th 2006 Page 1 of 22 CENTRE

More information

Human Fertilisation and Embryology Authority. Minutes of the Licence Committee

Human Fertilisation and Embryology Authority. Minutes of the Licence Committee Human Fertilisation and Embryology Authority Minutes of the Licence Committee Meeting held at Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8HF on 16 July 2015 Minutes item 2 Centre 0101 (CARE Nottingham)

More information

Interim Inspection Report. The Bridge Centre 0070

Interim Inspection Report. The Bridge Centre 0070 Interim Inspection Report The Bridge Centre 0070 Date of Inspection: 4 th March 2008 Date of Licence Committee: 11 th September 2008 Version: 0 Page 1 of 22 CENTRE DETAILS Centre Name The Bridge Centre

More information

Introduction 4. Important information about consent to legal parenthood 7. Women s consent to treatment and storage form (IVF and ICSI) (WT form) 9

Introduction 4. Important information about consent to legal parenthood 7. Women s consent to treatment and storage form (IVF and ICSI) (WT form) 9 Introduction 4 Important information about consent to legal parenthood 7 Women s consent to treatment and storage form (IVF and ICSI) (WT form) 9 Men s consent to treatment and storage form (IVF and ICSI)

More information

New Premises Inspection Report. Assisted Conception Unit Chelsea and Westminster Hospital. Centre Date of Inspection: 30 September 2009

New Premises Inspection Report. Assisted Conception Unit Chelsea and Westminster Hospital. Centre Date of Inspection: 30 September 2009 New Premises Inspection Report Assisted Conception Unit Chelsea and Westminster Hospital Centre 0158 Date of Inspection: 30 September 2009 Date of Executive Licence Panel: 23 October 2009 Version: 1 Page

More information

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception 1 Introduction Blackpool CCG Policies for the Commissioning of Healthcare Assisted Conception 1.1 This policy describes circumstances in which NHS Blackpool Clinical Commissioning Group (CCG) will fund

More information

Bromley CCG Assisted Conception Funding Form Checklist for Eligibility Criteria for NHS funding of Assisted Conception

Bromley CCG Assisted Conception Funding Form Checklist for Eligibility Criteria for NHS funding of Assisted Conception Bromley CCG Assisted Conception Funding Form Checklist for Eligibility Criteria for NHS funding of Assisted Conception This form is for the use of administrators of Assisted Conception Units to notify

More information

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception

More information

Cromwell IVF and Fertility Centre, Darlington (0075)

Cromwell IVF and Fertility Centre, Darlington (0075) Human Fertilisation and Embryology Authority Report of a renewal inspection at Cromwell IVF and Fertility Centre, Darlington (0075) October 2004 1 Contents Key facts about the centre... 3 Summary... 4

More information

Friday, 25 August 2017 HFEA, 10 Spring Gardens, London SW1A 2BU

Friday, 25 August 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Friday, 25 August 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Panel members Hannah Verdin (Chair) Anna Coundley Howard Ryan Head of Regulatory Policy Information Access and Policy Manager Report Developer

More information

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2. COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.3 2017 Agreed at Cannock Chase CCG Signature: Designation: Chair of

More information

Guide to Good Practice in fertility cases

Guide to Good Practice in fertility cases 2018 Guide to Good Practice in fertility cases This Guidance was reviewed in March 2018. The law or procedure may have changed since that time and members should check the up-to-date position. Resolution

More information

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO TREATMENT 3 4. DEFINITION

More information

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review

More information

HFEA Licence Committee Meeting 7 November 2013 Finsbury Tower, Bunhill Row, London, EC1Y 8HF

HFEA Licence Committee Meeting 7 November 2013 Finsbury Tower, Bunhill Row, London, EC1Y 8HF Minutes Item 8 HFEA Licence Committee Meeting 7 November 2013 Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8HF Centre 0101 (CARE Nottingham) Grade A Incident IN03434 and the preliminary findings of

More information

Compliance activities 2014/15: analysis of inspection findings

Compliance activities 2014/15: analysis of inspection findings Compliance activities 2014/15: analysis of inspection findings Strategic delivery: Setting standards Increasing and informing choice Demonstrating efficiency economy and value Details: Meeting Authority

More information

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO

More information

Your consent to donating your eggs

Your consent to donating your eggs HFEA WD form (Gender-neutral version) Your consent to donating your eggs About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator

More information

CODE OF PRACTICE FOR ASSISTED REPRODUCTIVE TECHNOLOGY UNITS INTERNATIONAL EDITION. Fertility Society of Australia

CODE OF PRACTICE FOR ASSISTED REPRODUCTIVE TECHNOLOGY UNITS INTERNATIONAL EDITION. Fertility Society of Australia CODE OF PRACTICE FOR ASSISTED REPRODUCTIVE TECHNOLOGY UNITS INTERNATIONAL EDITION Fertility Society of Australia Reproductive Technology Accreditation Committee (March 2014) Fertility Society of Australia

More information

Women s consent to the use and storage of eggs or embryos for surrogacy

Women s consent to the use and storage of eggs or embryos for surrogacy Women s consent to the use and storage of eggs or embryos for surrogacy HFEA WSG form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent

More information

Policy statement. Commissioning of Fertility treatments

Policy statement. Commissioning of Fertility treatments Policy statement Commissioning of Fertility treatments NB: The policy relating to commissioning of fertility treatments is unchanged from the version approved by the CCG in March 2017. The clinical thresholds

More information

Men s consent to the use and storage of sperm or embryos for surrogacy

Men s consent to the use and storage of sperm or embryos for surrogacy HFEA MSG form Men s consent to the use and storage of sperm or embryos for surrogacy About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent

More information

Interim Inspection Report. Glasgow Royal Infirmary 0037

Interim Inspection Report. Glasgow Royal Infirmary 0037 Interim Inspection Report Glasgow Royal Infirmary 0037 Date of Inspection: 7 th July 2006 Date of Licence Committee: 4 th September 2006 Page 1 of 24 CENTRE DETAILS Centre Address Glasgow Royal Infirmary

More information

Withdrawing your consent

Withdrawing your consent HFEA WC form Withdrawing your consent About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo

More information

IVF Hammersmith Hospital (0078) Date of inspection 26 th July Date of Licence Committee 30 th November 2005

IVF Hammersmith Hospital (0078) Date of inspection 26 th July Date of Licence Committee 30 th November 2005 Human Fertilisation and Embryology Authority Report of an interim inspection at IVF Hammersmith Hospital (0078) Date of inspection 26 th July 2005 Date of Licence Committee 30 th November 2005 1 Contents

More information

D D M M Y Y D D M M Y Y. For clinic use only (optional) MD PNT only (gender-neutral): version 1; 3 April 2017

D D M M Y Y D D M M Y Y. For clinic use only (optional) MD PNT only (gender-neutral): version 1; 3 April 2017 This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo research. For more information about us, visit www.hfea.gov.uk.

More information

HFEA Licence Committee Meeting 9 January 2014 Finsbury Tower, Bunhill Row, London, EC1Y 8HF

HFEA Licence Committee Meeting 9 January 2014 Finsbury Tower, Bunhill Row, London, EC1Y 8HF Minutes Item 7 HFEA Licence Committee Meeting 9 January 2014 Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8HF Centre 0101 (CARE Nottingham) - Grade A Incident Report Members of the Committee: Andy

More information

SPECIALIST FERTILITY SERVICES CLINICAL CRITERIA & CONTRACT AWARD

SPECIALIST FERTILITY SERVICES CLINICAL CRITERIA & CONTRACT AWARD AGENDA ITEM 8 GOVERNING BODY MEETING IN PUBLIC ON 25 TH SEPTEMBER 2014 SPECIALIST FERTILITY SERVICES CLINICAL CRITERIA & CONTRACT AWARD Date of the meeting 25 th September 2014 Author Sponsoring Board

More information

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES Version number V2.3 Responsible individual Author(s) Barry Weaver Trish

More information

Regulating mitochondrial donation: seeking expert views. Background document

Regulating mitochondrial donation: seeking expert views. Background document Regulating mitochondrial donation: seeking expert views Background document June 2015 Contents Introduction 3 What we need from you 3 Licensing mitochondrial donation 4 Licensing the clinic to undertake

More information

Haringey CCG Fertility Policy April 2014

Haringey CCG Fertility Policy April 2014 Haringey CCG Fertility Policy April 2014 1 SUMMARY This policy describes the clinical pathways and entry criteria for Haringey patients wishing to access NHS funded fertility treatment. 2 RESPONSIBLE PERSON:

More information

[Act on Artificial Fertilisation and use of Human Gametes and Embryos for Stem-Cell Research] 1) No. 55/1996 1) Act No. 27/2008, Article 9

[Act on Artificial Fertilisation and use of Human Gametes and Embryos for Stem-Cell Research] 1) No. 55/1996 1) Act No. 27/2008, Article 9 [Act on Artificial Fertilisation and use of Human Gametes and Embryos for Stem-Cell Research] 1) No. 55/1996 1) Act No. 27/2008, Article 9 as amended by Act No. 65/2006, Act No. 27/2008, Act No. 54/2008,

More information

Recommended Interim Policy Statement 150: Assisted Conception Services

Recommended Interim Policy Statement 150: Assisted Conception Services Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations

More information

THE LAW - CONCEPTION USING DONOR EGGS OR SPERM

THE LAW - CONCEPTION USING DONOR EGGS OR SPERM Assisted Conception Unit 11 th Floor, Tower Wing Guy s Hospital, Great Maze Pond London SE1 9RT Tel:.020 7188 2300 Fax: 020 7188 0490 THE LAW - CONCEPTION USING DONOR EGGS OR SPERM Introduction If you

More information

Initial Licence Inspection Report

Initial Licence Inspection Report Initial Licence Inspection Report Date of Inspection: 5 May 2010. Length of inspection: 6 hours. Inspectors: Bhavna Mehta, Ellie Suthers and Wil Lenton. Inspection details: The report covers the pre-inspection

More information

Director of Commissioning, Telford and Wrekin CCG and Shropshire CCG. Version No. Approval Date August 2015 Review Date August 2017

Director of Commissioning, Telford and Wrekin CCG and Shropshire CCG. Version No. Approval Date August 2015 Review Date August 2017 Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services, in Shropshire and Telford and Wrekin Owner(s) Version No. Director of

More information

Your consent to disclosing identifying information

Your consent to disclosing identifying information Your consent to disclosing identifying information HFEA CD form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility

More information

West Hampshire Clinical Commissioning Group Board

West Hampshire Clinical Commissioning Group Board West Hampshire Clinical Commissioning Group Board Date of meeting 25 July 2013 Agenda Item 9 Paper No WHCCG13/089 Priorities Committee Statement Assisted Conception/IVF Key issues An Interim Policy Statement

More information

About this guidance. Introduction. When there are no children on roll

About this guidance. Introduction. When there are no children on roll The process and guidance for inspecting childminders and childcare settings with no children on roll or no children present at the time of the inspection About this guidance The aim of this guidance is

More information

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Patient Name (please print) Patient DOB (MM/DD/YYYY) Patient eivf number Partner

More information

Paper. Donation review conditional donation. Hannah Darby, Policy Manager. Decision

Paper. Donation review conditional donation. Hannah Darby, Policy Manager. Decision Paper Paper Title: Donation review conditional donation Paper Number: ELAC (06/11)2 Meeting Date: 8 June 2011 Agenda Item: 7 Author: For information or decision? Recommendation to the Annexes Hannah Darby,

More information

New Centre Licence Inspection Report

New Centre Licence Inspection Report New Centre Licence Inspection Report Date of Inspection: 19 November 2009 Length of inspection: 5 hours Inspectors: Dr Chris O Toole Dr Maybeth Jamieson Ms Mim Glenn Inspection details: The report covers

More information

Research Licence Inspection Report

Research Licence Inspection Report Research Licence Inspection Report Project Title Studies of embryo development and metabolism Centre Name Assisted Conception Unit, Ninewells Hospital and Medical School Centre Number Centre 0004 Research

More information

Application to import or export donor sperm, eggs or embryos

Application to import or export donor sperm, eggs or embryos donor sperm, eggs or embryos Effective: 1 Applying to import or export The import and export of donor sperm, donor eggs and embryos produced using donor sperm and/or eggs is governed in Victoria by the

More information

Interim Inspection Report. Care Manchester 0185

Interim Inspection Report. Care Manchester 0185 Interim Inspection Report Care Manchester 0185 Date of Inspection: 20 th March 2007 Date of Licence Committee: 15 th August 2007 Page 1 of 18 CENTRE DETAILS Centre Address 108-112 Daisy Bank Road Victoria

More information

Clinical Policy Committee

Clinical Policy Committee Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year

More information

College of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE

College of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE College of Physicians and Surgeons of Saskatchewan STANDARDS Assisted Reproductive Technology STATUS: UNDER REVIEW Approved by Council: September 2012 Amended: November 2015 To be reviewed: November 2020

More information

TERMS AND CONDITIONS NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY

TERMS AND CONDITIONS NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY TERMS AND CONDITIONS OF NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY FOR OBTAINING AND MAINTAINING ITS GLP CERTIFICATION BY A TEST FACILITY Document No.GLP-101 Version/Issue

More information

Your consent to the storage of your eggs or sperm

Your consent to the storage of your eggs or sperm Your consent to the storage of your eggs or sperm HFEA GS form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility

More information

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH ANONYMOUS DONOR SPERM

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH ANONYMOUS DONOR SPERM THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH ANONYMOUS DONOR SPERM Partner #1 Last Name (Surname): Partner #1 First Name: Partner

More information

GOVERNING BODY MEETING IN VITRO FERTILISATION (IVF) AND ASSISTED CONCEPTION CONSULTATION. Matt Rangué, Chief Nurse, NHS Southend CCG

GOVERNING BODY MEETING IN VITRO FERTILISATION (IVF) AND ASSISTED CONCEPTION CONSULTATION. Matt Rangué, Chief Nurse, NHS Southend CCG AGENDA ITEM 5. GOVERNING BODY MEETING IN VITRO FERTILISATION (IVF) AND ASSISTED CONCEPTION CONSULTATION Date of the meeting 1 st February 2018 Author Sponsoring Governing Body Member Purpose of Report

More information

Sperm Donation - Information for Donors

Sperm Donation - Information for Donors Sperm Donation - Information for Donors The donation of sperm to help someone to have a child is one of the most generous gifts anyone can give. Many donors feel a sense of pride, knowing the joy they

More information

SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)

SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs) SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs) Policy Recommendation 002: Assisted Conception Services Date of Issue: September 2014

More information

Ethical guidelines on the use of assisted reproductive technology in clinical practice and research

Ethical guidelines on the use of assisted reproductive technology in clinical practice and research Ethical guidelines on the use of assisted reproductive technology in clinical practice and research AUSTRALIAN HEALTH ETHICS COMMITTEE Endorsed by NHMRC for public release in September 2004 September 2004

More information

Interim Inspection Report

Interim Inspection Report Interim Inspection Report The Lister Fertility Clinic 0006 Date of Inspection: 11 th October 2007 Date of Licence Committee: 28 January 2008 Page 1 of 27 CENTRE DETAILS Centre Address The Lister Hospital

More information

Fill in this form if you are donating eggs and/or embryos created with your eggs for use in another person s mitochondrial donation

Fill in this form if you are donating eggs and/or embryos created with your eggs for use in another person s mitochondrial donation This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo research. For more information about us, visit www.hfea.gov.uk.

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments

More information

Fertility Policy. December Introduction

Fertility Policy. December Introduction Fertility Policy December 2015 Introduction Camden Clinical Commissioning Group (CCG) is responsible for commissioning a range of health services including hospital, mental health and community services

More information

CONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP

CONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP CONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP 1. AIMS To unify and co-ordinate services for children, young people and families in line with the Children Act 2004 To oversee the

More information

Women s consent to treatment and storage form (IVF and ICSI)

Women s consent to treatment and storage form (IVF and ICSI) Women s consent to treatment and storage form (IVF and ICSI) HFEA WT form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator

More information

Research Licence Interim Inspection Report

Research Licence Interim Inspection Report Research Licence Interim Inspection Report Project Title Centre Name Investigation into the role of sperm PLCzeta in human oocyte activation IVF Wales Centre Number 0049 Research licence Number R0161 Centre

More information

Medical gap arrangements - practitioner application

Medical gap arrangements - practitioner application Medical gap arrangements - practitioner application For services provided in a licensed private hospital or day hospital facility (Private Hospital) only. Please complete this form to apply for participation

More information

COMPETENCES REQUIRED FOR APPLICANTS TO ATTAIN HPC REGISTRATION AS CLINICAL SCIENTISTS

COMPETENCES REQUIRED FOR APPLICANTS TO ATTAIN HPC REGISTRATION AS CLINICAL SCIENTISTS This document comprises a discipline-specific version of the general competence document and provides additional guidance as to how to complete the general document, Appendix 1 of the Guidelines, that

More information

Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI)

Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI) HFEA MT form (Gender-neutral version) Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI) About this form This form is produced by the Human Fertilisation and Embryology

More information

Information For Egg Recipients

Information For Egg Recipients Egg Recipients Royal Devon and Exeter NHS Foundation Trust Information For Egg Recipients What is egg donation? Egg donation is a type of in-vitro fertilisation (IVF) treatment in which eggs are collected

More information

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian 1. Introduction The provision of Substance Misuse (SM) services through

More information

FERTILITY SERVICE POLICY

FERTILITY SERVICE POLICY FERTILITY SERVICE POLICY Page 1 of 8 FERTILITY SERVICE POLICY Please note that all Clinical Commissioning policies are currently under review and elements within the individual policies may have been replaced

More information

Centre for Reproductive Medicine and Fertility Jessop Wing Tree Root Walk Sheffield S10 3SF

Centre for Reproductive Medicine and Fertility Jessop Wing Tree Root Walk Sheffield S10 3SF Assisted Conception Unit Consultants: Prof William Ledger Mr Jonathan Skull (Clinical Head) Mr TC Li Mr Hany Lashen Clinical Nurse Specialist Anne Mowforth Scientific Staff Dr Karen Martin (Head of Embryology)

More information

REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS. 19 November 1996 No I-1626 Vilnius

REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS. 19 November 1996 No I-1626 Vilnius REPUBLIC OF LITHUANIA LAW ON DONATION AND TRANSPLANTATION OF HUMAN TISSUES, CELLS AND ORGANS 19 November 1996 No I-1626 Vilnius (As last amended on 12 May 2016 No XII-2344) CHAPTER I GENERAL PROVISIONS

More information

Research Licence Inspection Report

Research Licence Inspection Report Research Licence Inspection Report Project Title Research licence Number Person Responsible Nominal Licensee Inspection type Date application fee paid A novel approach for extracting cells during embryo

More information

Placename CCG. Policies for the Commissioning of Healthcare. Policy for Assisted Conception Services

Placename CCG. Policies for the Commissioning of Healthcare. Policy for Assisted Conception Services Placename CCG Policies for the Commissioning of Healthcare Policy for Assisted Conception Services 1 Introduction 1.1 This document is part of a suite of policies that the CCG uses to drive its commissioning

More information

GOVERNING BOARD. Assisted Conception (IVF): Review of access criteria. Date of Meeting 21 January 2015 Agenda Item No 13. Title

GOVERNING BOARD. Assisted Conception (IVF): Review of access criteria. Date of Meeting 21 January 2015 Agenda Item No 13. Title GOVERNING BOARD Date of Meeting 21 January 2015 Agenda Item No 13 Title Assisted Conception (IVF): Review of access criteria Purpose of Paper The SHIP (Southampton, Hampshire, Isle of Wight and Portsmouth)

More information

Assisted Conception Policy

Assisted Conception Policy Assisted Conception Policy NHS Eligibility Criteria for assisted conception services (excluding In vitro fertilisation (IVF) Intracytoplasmic sperm injection (ICSI) treatment) for people with infertility

More information

Health Scrutiny Panel 6 February 2014

Health Scrutiny Panel 6 February 2014 Agenda Item No: 5 Health Scrutiny Panel 6 February 2014 Report title Infertility Policy Review Wolverhampton Clinical Commissioning Group Cabinet member with lead responsibility Wards affected Accountable

More information

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental

More information

CONSENT FOR CRYOPRESERVATION OF EMBRYOS

CONSENT FOR CRYOPRESERVATION OF EMBRYOS CONSENT FOR CRYOPRESERVATION OF EMBRYOS We, (Female Partner) and (Partner, Spouse), as participants in the in vitro fertilization (IVF) program at the Reproductive fertility center (REPRODUCTIVE FERTILITY

More information

IVF. NHS North West London CCGs

IVF. NHS North West London CCGs IVF NHS North West London CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services Adopted by NWL CCGs to be effective from

More information

DIRECTIVES. (Text with EEA relevance)

DIRECTIVES. (Text with EEA relevance) L 238/44 DIRECTIVES COMMISSION DIRECTIVE (EU) 2017/1572 of 15 September 2017 supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of

More information

Human Fertilisation and Embryology Authority

Human Fertilisation and Embryology Authority response to the Human Fertilisation and Embryology Authority public consultation on The 7 th Edition of the Code of Practice December 2006 This document represents the British Fertility Society (BFS) response

More information

Care and Social Services Inspectorate Wales

Care and Social Services Inspectorate Wales Care and Social Services Inspectorate Wales Service Regulation and Inspection Guidance on inspecting welfare provision in boarding schools, residential special schools and accommodation of students under

More information

Friday, 25 August 2017 HFEA, 10 Spring Gardens, London SW1A 2BU

Friday, 25 August 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Friday, 25 August 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Panel members Hannah Verdin (Chair) Anna Coundley Howard Ryan Head of Regulatory Policy Information Access and Policy Manager Report Developer

More information

North Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria

North Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria North Staffordshire Clinical Commissioning Group Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria Policy Infertility and Assisted Reproduction Commissioning Policy and

More information